Susquehanna International Group
SURF

Susquehanna International Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Susquehanna International Group’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-52,149
Closed -$45.3K – 13379
2023
Q2 		$45.3K Buy
52,149
+37,934
+267% +$27.1K ﹤0.01% 11376
2023
Q1 		$9.93K Sell
14,215
-35,600
-71% -$28.8K ﹤0.01% 12212
2022
Q4 		$40.8K Buy
49,815
+25,903
+108% +$25.5K ﹤0.01% 11502
2022
Q3 		$25K Sell
23,912
-7,134
-23% -$11.4K ﹤0.01% 12523
2022
Q2 		$51K Sell
31,046
-2,319
-7% -$4.82K ﹤0.01% 11970
2022
Q1 		$98K Sell
33,365
-53,945
-62% -$189K ﹤0.01% 11932
2021
Q4 		$417K Buy
87,310
+53,330
+157% +$344K ﹤0.01% 9660
2021
Q3 		$258K Sell
33,980
-74,545
-69% -$477K ﹤0.01% 10948
2021
Q2 		$810K Sell
108,525
-299,985
-73% -$2.31M ﹤0.01% 8337
2021
Q1 		$3.19M Buy
408,510
+205,705
+101% +$2.06M ﹤0.01% 4824
2020
Q4 		$1.87M Buy
+202,805
New +$1.76M ﹤0.01% 5236

Susquehanna International Group's SURF Position: Q3 2023 in Review

Susquehanna International Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 52,149 shares — an estimated $45.3K sold.

Susquehanna International Group first reported a position in SURF in Q4 2020 and held it in 11 quarters. The position peaked at $3.19M in Q1 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • Susquehanna International Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 52,149 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $45.3K.
  • Susquehanna International Group first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Susquehanna International Group's Surface Oncology, Inc. Common Stock position peaked at $3.19M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.